Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatment

Clinical Rheumatology

Volumn 29, Issue 10, 2010, Pages 1201-1204

  Lynch, Karen ^a,b   Farrell, Michael ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adalimumab; Anti TNF; Cerebral; Rheumatoid arthritis; Tuberculoma

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ARTICLE; BRAIN DISEASE; CASE REPORT; FEMALE; HUMAN; INTRACRANIAL TUBERCULOMA; MIDDLE AGED; PARIETAL LOBE; PATHOLOGY; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRAIN DISEASES; FEMALE; HUMANS; MIDDLE AGED; PARIETAL LOBE; TREATMENT OUTCOME; TUBERCULOMA, INTRACRANIAL;

EID: 79952111267     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-010-1466-7     Document Type: Article

References (15)

1. Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A (2008) Tumor necrosis factor alpha drugs in rheumatoid arthritis: systemic review and metanalysis of efficacy and safety. BMC Musculoskelet Disord 17(9):52, Review
2. Dimakou K, Papaioannides D, Latsi P, Katsimboula S, Korantzopoulos P, Orphanidou D (2004) Disseminated tuberculosis complicating anti-TNF-A treatment. Int J Clin Pract 58(11):1052-1055
3. Askling J, Fored CM, Brandt L et al (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52:1986-1992
4. Bongartz T, Sutton AJ, Sweeting MJ et al (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-Analysis of rare harmful effects in randomized controlled trials. JAMA 295 (19):2275-2285
5. Furst DE, Schiff MH, Fleischmann RM et al (2003) Adalimumab, a fully human anti tumor necrosis factor-Alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 30(12):2563-2571
6. Keane J, Gershon S et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor-neutralizing agent. N Engl J Med 345:1098-1104
7. Raval A, Akhavan-Toyserkani G et al (2007) Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab. Ann Intern Med 147:699
8. Ubukata M et al (2005) Pulmonary TB with cerebellar lesion in a patient after anti-TNF alpha (infliximab) treatment for rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi 43(4):247-51, Article in Japanese
9. Fonscea JE, Canhao H, Silva C et al (2006) Tuberculosis in rheumatic patients treated with tumor necrosis alpha antagonists: the Portuguese experience. Acta Reumatol Port 31:247-253
10. Schiff et al (2006) Safety analyses of adalimumab (Humira) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis. Ann Rheum Dis 65:889-894
11. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766-1772
12. CDC. Extrapulmonary tuberculosis cases and percentages of site of disease: reporting areas, 2005. Centers of Disease Control and Prevention, Atlanta, Georgia. www.cdc.gov/tb/surv/surv2005/PDF/table27.pdf
13. Pai M, Flores L et al (2003) Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-Analysis. Lancet Infect Dis 3:633-643
14. Sumi MG, Mathai A et al (2001) Diagnostic utility of polymerase chain reaction and immunohistochemical techniques for the laboratory diagnosis of intracranial tuberculoma. Clin Neuropathol 20:176-180
15. Thwaites GE, Nguyen DB et al (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351:1741-1751